Welcome to the Team

09.04.2021

May we introduce you to: Aljoša Smajić, the new #pharminfo PhD student. We are very happy that you are starting your PhD journey together with us and are looking forward to your results already. Welcome Aljoša!

Aljoša Smajić is a PhD student within the MolTag program. The aim of his doctoral project is the establishment of novel paths for the creation of predictive models in the field of toxicity prediction. The results can address privacy and governance challenges and provide controlled, indirect access to large and comprehensive datasets for the development of ML & DL algorithms. He is, in addition to his doctoral project, involved in the eTRANSAFE project for the prediction of in vivo toxicity in humans based on animal testing data.

Back

Related Links

MolTag Website "Ion channels and transporters as molecular drug targets"
Aljoša Smajić #pharminfo

More News

News

AI4Health Project recognized as finalist at Mercur Innovation Award

The AI4Health project, a joint initiative by Robimo GmbH, spin-off of the University of Vienna, and the Pharmacoinformatics Research Group led by...

More

Open Access

Careful Examination of a Novel Azobenzene Paroxetine Derivative and Its Interactions With Biogenic Amine Transporters

SERT belongs to the monoamine NTTs, regulating the extracellular concentration of serotonin and thereby maintaining serotonergic neurotransmission....

More

Open Access

Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets

Combining bioactivity data from different sources for ML predictions can lead to high variance in values and differences in chemical space. This study...

More